RJFSA
TDOC icon

Raymond James Financial Services Advisors’s Teladoc Health TDOC Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$197K Sell
21,505
-13,875
-39% -$115K ﹤0.01% 3192
2024
Q2 		$346K Sell
35,380
-769
-2% -$9.38K ﹤0.01% 2788
2024
Q1 		$546K Sell
36,149
-3,138
-8% -$56.9K ﹤0.01% 2448
2023
Q4 		$847K Buy
39,287
+3,582
+10% +$66.1K ﹤0.01% 2087
2023
Q3 		$664K Buy
35,705
+22,670
+174% +$529K ﹤0.01% 2150
2023
Q2 		$330K Sell
13,035
-7,052
-35% -$177K ﹤0.01% 2601
2023
Q1 		$520K Sell
20,087
-2,454
-11% -$65.7K ﹤0.01% 2313
2022
Q4 		$533K Sell
22,541
-7,000
-24% -$189K ﹤0.01% 2226
2022
Q3 		$749K Sell
29,541
-2,187
-7% -$76.7K ﹤0.01% 2005
2022
Q2 		$1.05M Sell
31,728
-3,552
-10% -$151K ﹤0.01% 1796
2022
Q1 		$2.54M Buy
35,280
+10,143
+40% +$731K ﹤0.01% 1357
2021
Q4 		$2.31M Sell
25,137
-12,068
-32% -$1.44M ﹤0.01% 1441
2021
Q3 		$4.72M Sell
37,205
-17,351
-32% -$2.53M 0.01% 1006
2021
Q2 		$9.07M Sell
54,556
-8,369
-13% -$1.36M 0.02% 698
2021
Q1 		$11.4M Sell
62,925
-3,726
-6% -$864K 0.03% 571
2020
Q4 		$13.3M Buy
66,651
+6,071
+10% +$1.23M 0.03% 468
2020
Q3 		$13.3M Sell
60,580
-1,689
-3% -$358K 0.04% 417
2020
Q2 		$11.9M Buy
62,269
+8,995
+17% +$1.58M 0.04% 421
2020
Q1 		$8.26M Buy
53,274
+30,784
+137% +$3.58M 0.04% 414
2019
Q4 		$1.88M Buy
22,490
+1,366
+6% +$104K 0.01% 1196
2019
Q3 		$1.43M Sell
21,124
-388
-2% -$25.5K 0.01% 1281
2019
Q2 		$1.43M Sell
21,512
-5,792
-21% -$338K 0.01% 1290
2019
Q1 		$1.52M Sell
27,304
-293
-1% -$17.9K 0.01% 1217
2018
Q4 		$1.37M Sell
27,597
-8,827
-24% -$540K 0.01% 1107
2018
Q3 		$3.15M Buy
36,424
+12,688
+53% +$904K 0.01% 834
2018
Q2 		$1.38M Buy
23,736
+13,883
+141% +$678K 0.01% 1229
2018
Q1 		$397K Buy
9,853
+2,765
+39% +$104K ﹤0.01% 1858
2017
Q4 		$247K Sell
7,088
-2,458
-26% -$81.6K ﹤0.01% 2130
2017
Q3 		$316K Buy
9,546
+3,714
+64% +$122K ﹤0.01% 1994
2017
Q2 		$202K Buy
+5,832
New +$170K ﹤0.01% 2230

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Raymond James Financial Services Advisors's TDOC Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Teladoc Health (TDOC) stake by 39% in Q3 2024, selling an estimated $115K and leaving 21,505 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

Raymond James Financial Services Advisors first reported a position in TDOC in Q2 2017 and has held it in 30 quarters since. The position peaked at $13.3M in Q4 2020. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Raymond James Financial Services Advisors held 21,505 shares of Teladoc Health worth $197K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 13,875 Teladoc Health shares in Q3 2024, an estimated $115K.
  • Teladoc Health made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3192 holding.
  • Raymond James Financial Services Advisors first reported a position in Teladoc Health in Q2 2017 and has held it in 30 quarters since.
  • Raymond James Financial Services Advisors's Teladoc Health position peaked at $13.3M in Q4 2020.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.